The truth in small doses : why we're losing the war on cancer-and how to win it / Clifton Leaf.

By: Material type: TextTextPublication details: New York : Simon & Schuster, Description: 499 pages : illustrations ; 24 cmContent type:
  • text
Media type:
  • unmediated
Carrier type:
  • volume
ISBN:
  • 9781476739984
  • 1476739986
  • 9781476739991
  • 1476739994
  • 9781476740003
  • 1476740003
Subject(s): Genre/Form: DDC classification:
  • 616.99/4061 23
LOC classification:
  • RC271.C5 L43 2013
NLM classification:
  • QZ 201
Contents:
Counting -- The truth in small doses -- A war of attrition -- The soldier -- The little orange pill -- Missing the target -- Preemption -- The wrong bill -- The door question -- Publish and perish -- Deadly caution -- Reversal of fortune -- Fossils -- The one-eyed surgeon -- Matterhorn.
Summary: A decade ago Leaf, a cancer survivor himself, began to investigate why we had made such limited progress fighting this terrifying disease. The result is a gripping narrative that reveals why the public's immense investment in research has been badly misspent, why scientists seldom collaborate and share their data, why new drugs are so expensive yet routinely fail, and why our best hope for progress-- brilliant young scientists-- are now abandoning the search for a cure.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Call number Copy number Status Date due Barcode
Books Books Odessa College Stacks 616.994 L434T (Browse shelf(Opens below)) 1 Available 51994001683848

Includes bibliographical references (pages 393-480) and index.

Counting -- The truth in small doses -- A war of attrition -- The soldier -- The little orange pill -- Missing the target -- Preemption -- The wrong bill -- The door question -- Publish and perish -- Deadly caution -- Reversal of fortune -- Fossils -- The one-eyed surgeon -- Matterhorn.

A decade ago Leaf, a cancer survivor himself, began to investigate why we had made such limited progress fighting this terrifying disease. The result is a gripping narrative that reveals why the public's immense investment in research has been badly misspent, why scientists seldom collaborate and share their data, why new drugs are so expensive yet routinely fail, and why our best hope for progress-- brilliant young scientists-- are now abandoning the search for a cure.

There are no comments on this title.

to post a comment.